MedTrace Logo

Remote Monitoring of Patients With Functional Mitral Regurgitation Undergoing Mitraclip Transcatheter Repair

NCT02698150 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2017-09-11

No results posted yet for this study

Summary

HERMES is a pilot study which aims at exploring the impact of remote monitoring in patients with severe functional mitral regurgitation undergoing transcatheter mitral valve edge-to-edge repair with the Mitraclip system.

Conditions

Interventions

DEVICE

HERMES tablet

Tablet, sensors and wearables for daily collection of clinical data

Sponsors & Collaborators

  • Abbott Medical Devices

    collaborator INDUSTRY

  • Azienda Ospedaliero, Ferrarotto Alessi

    lead OTHER

Principal Investigators

  • Corrado Tamburino, Professor · Ferrarotto Hospital, University of Catania

  • Carmelo Grasso, MD · Ferrarotto Hospital, University of Catania

  • Davide Capodanno, MD, PhD · Ferrarotto Hospital, University of Catania

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-09-30
Completion
2018-10-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02698150 on ClinicalTrials.gov